Gail McIntyre

Title: Gail McIntyre: Innovator in Opioid Receptor Modulation

Introduction

Gail McIntyre is a prominent inventor based in Lansdale, PA (US). She has made significant contributions to the field of pharmaceutical formulations, particularly in the area of opioid receptor modulators. Her innovative work aims to enhance the safety and efficacy of medications.

Latest Patents

Gail McIntyre holds a patent for "Opioid receptor modulator dosage formulations." This patent includes abuse deterrent solid dosage formulations containing 5-({[2-Amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid, along with processes for the preparation and administration of these formulations. This patent represents her commitment to addressing the challenges associated with opioid use.

Career Highlights

Throughout her career, Gail has demonstrated a strong dedication to research and development in the pharmaceutical industry. She is currently associated with Allergan Holdings Unlimited Company, where she continues to innovate and contribute to the advancement of drug formulations.

Collaborations

Gail has worked alongside notable colleagues such as Tim Costello and Leonard Scott Dove. Their collaborative efforts have furthered the development of effective pharmaceutical solutions.

Conclusion

Gail McIntyre's work in opioid receptor modulation showcases her innovative spirit and dedication to improving healthcare. Her contributions are vital in the ongoing efforts to create safer medication options for patients.